Delota Valuation
Is NIC undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of NIC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: NIC (CA$0.11) is trading below our estimate of fair value (CA$1.84)
Significantly Below Fair Value: NIC is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for NIC?
Key metric: As NIC is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is NIC's PS Ratio? | |
|---|---|
| PS Ratio | 0.08x |
| Sales | CA$37.88m |
| Market Cap | CA$3.06m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.2x |
| Enterprise Value/EBITDA | 7.3x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does NIC's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.6x | ||
PESO PesoRama | 0.5x | n/a | CA$12.9m |
SNYB Shiny Health & Wellness | 0.03x | n/a | CA$598.1k |
IDG Indigo Books & Music | 0.07x | -1.6% | CA$68.9m |
KITS Kits Eyecare | 1.9x | 18.5% | CA$279.5m |
NIC Delota | 0.08x | n/a | CA$3.1m |
Price-To-Sales vs Peers: NIC is good value based on its Price-To-Sales Ratio (0.1x) compared to the peer average (0.6x).
Price to Sales Ratio vs Industry
How does NIC's PS Ratio compare vs other companies in the CA Specialty Retail Industry?
Price-To-Sales vs Industry: NIC is good value based on its Price-To-Sales Ratio (0.1x) compared to the North American Specialty Retail industry average (0.5x).
Price to Sales Ratio vs Fair Ratio
What is NIC's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.08x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate NIC's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Aritzia
CA$4.9b
Designs, develops, and sells apparels and accessories for women in the United States and Canada.
ATZ
CA$43.33
7D
-5.0%
1Y
79.0%
Reitmans (Canada)
US$95.3m
Primarily engages in the retail sale of women’s specialty apparel in Canada under the Reitmans, Penningtons, and RW&CO brand names.
RET.A
US$2.59
7D
3.6%
1Y
1.6%
Reitmans (Canada)
US$95.0m
Primarily engages in the retail sale of women’s specialty apparel in Canada under the Reitmans, Penningtons, and RW&CO brand names.
RET
US$2.75
7D
-1.1%
1Y
-8.3%